Moneycontrol
HomeNewsBusinessCompaniesDid not want co-pay to become a constraint for senior citizens during COVID-19: Prasun Sikdar, CEO, ManipalCigna
Trending Topics

Did not want co-pay to become a constraint for senior citizens during COVID-19: Prasun Sikdar, CEO, ManipalCigna

In health insurance policies, co-pay refers to an arrangement where the policyholder is required to pay a fixed portion of the medical expenses (claims) out of their own pocket while the insurer pays the rest.

May 26, 2020 / 18:12 IST
Story continues below Advertisement

Prasun Sikdar, MD & CEO, ManipalCigna Health Insurance

Amidst the COVID-19 outbreak, there are concerns among senior citizens about hospitalisation costs. To ensure that they do not face financial constraints, ManipalCigna Health Insurance has waived the 20 percent mandatory co-pay clause for individuals aged 65 years and above.

In an interaction with Moneycontrol, Prasun Sikdar, MD & CEO, ManipalCigna Health Insurance, said the idea was to protect the financial security of senior citizens.

Story continues below Advertisement

"During the COVID-19 outbreak, we did not want senior citizens to any face any financial difficulty since there us a co-pay element in the policy. Hence, we have waived it for four months till August 2020," he said.

Also read: Live updates on the Coronavirus outbreak in India

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show